Arkadios Wealth Advisors Bristol Myers Squibb CO Transaction History

Arkadios Wealth Advisors

  • $1.64 Billion
  • Q3 2024

A detailed history of Arkadios Wealth Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Arkadios Wealth Advisors holds 138,427 shares of BMY stock, worth $8.15 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
138,427
Previous 47,731 190.01%
Holding current value
$8.15 Million
Previous $1.98 Million 261.4%
% of portfolio
0.44%
Previous 0.14%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
BUY
$39.66 - $51.75 $3.6 Million - $4.69 Million
90,696 Added 190.01%
138,427 $7.16 Million
Q2 2024

Jul 29, 2024
BUY
$40.25 - $52.99 $406,927 - $535,728
10,110 Added 26.87%
47,731 $1.98 Million
Q1 2024

Apr 30, 2024
BUY
$47.98 - $54.4 $338,546 - $383,846
7,056 Added 23.09%
37,621 $2.04 Million
Q4 2023

Jan 24, 2024
SELL
$48.48 - $57.85 $504,579 - $602,102
-10,408 Reduced 25.4%
30,565 $1.57 Million
Q3 2023

Oct 13, 2023
BUY
$57.89 - $64.73 $1.06 Million - $1.19 Million
18,339 Added 81.02%
40,973 $2.38 Million
Q2 2023

Jul 26, 2023
BUY
$63.71 - $70.74 $67,405 - $74,842
1,058 Added 4.9%
22,634 $1.45 Million
Q1 2023

May 02, 2023
SELL
$65.71 - $74.53 $35,811 - $40,618
-545 Reduced 2.46%
21,576 $1.5 Million
Q4 2022

Jan 11, 2023
BUY
$68.48 - $81.09 $294,669 - $348,930
4,303 Added 24.15%
22,121 $0
Q3 2022

Oct 21, 2022
BUY
$0.13 - $76.84 $46 - $27,508
358 Added 2.05%
17,818 $1.27 Million
Q2 2022

Jul 14, 2022
BUY
$72.62 - $79.98 $262,012 - $288,567
3,608 Added 26.05%
17,460 $1.34 Million
Q1 2022

May 02, 2022
BUY
$61.48 - $73.72 $169,930 - $203,762
2,764 Added 24.93%
13,852 $1.01 Million
Q4 2021

Feb 03, 2022
SELL
$53.63 - $62.52 $156,116 - $181,995
-2,911 Reduced 20.79%
11,088 $691,000
Q3 2021

Oct 19, 2021
SELL
$59.17 - $69.31 $160,350 - $187,830
-2,710 Reduced 16.22%
13,999 $828,000
Q2 2021

Jul 28, 2021
BUY
$61.91 - $67.42 $274,013 - $298,400
4,426 Added 36.03%
16,709 $1.12 Million
Q1 2021

Apr 26, 2021
BUY
$59.34 - $66.74 $211,784 - $238,195
3,569 Added 40.96%
12,283 $775,000
Q4 2020

Feb 09, 2021
BUY
$57.74 - $65.43 $367,977 - $416,985
6,373 Added 272.23%
8,714 $540,000
Q3 2020

Nov 10, 2020
SELL
$57.43 - $63.64 $1,550 - $1,718
-27 Reduced 1.14%
2,341 $143 Million
Q2 2020

Aug 10, 2020
BUY
$54.82 - $64.09 $3,289 - $3,845
60 Added 2.6%
2,368 $137 Million
Q1 2020

May 14, 2020
SELL
$46.4 - $67.43 $7,284 - $10,586
-157 Reduced 6.37%
2,308 $129 Million
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $121,302 - $158,228
2,465 New
2,465 $158,000

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Arkadios Wealth Advisors Portfolio

Follow Arkadios Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Arkadios Wealth Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email